Navigation Links
Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
Date:2/3/2009

MOUNTAIN VIEW, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that company President and CEO Thomas B. King will present during the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009 at 2:45 p.m. ET. The presentation will be webcast from the Waldorf-Astoria Hotel in New York, NY.

To access the presentation via the Web, please go to the Investor Relations tab at www.alexza.com or at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ALXA&item_id=2079439. A replay of the webcast will be made available approximately 24 hours after the live presentation and the replay will be archived for 14 days.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Alexza's lead program is AZ-004 (Staccato loxapine) and is being developed for the acute treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, and is projecting a New Drug Application submission in early 2010.
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. Signalife Provides Corporate Update
5. Biomira Announces Plan to Reincorporate in the United States
6. Pressure BioSciences, Inc. Provides Corporate Update
7. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
8. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
9. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... on technologies and applications. The report starts with ... estimation of markets. Technologies include array comparative genomic ...
(Date:9/2/2015)... , September 2, 2015 Biovista ... winners of the 2015 BeHEARD science challenge, a global ... rare disease researchers, access to the latest life science ... drug repositioning and pathway analytics capability to support ... Foundation in the study of Niemann-Pick Disease Type A ...
(Date:9/2/2015)... 2, 2015 Veracyte, Inc. (NASDAQ: VCYT ... president and chief executive officer, will present at the ... 2015 at 10:30 a.m. ET in New ... audio webcast and subsequent replay may be accessed by ... available shortly after conclusion of the presentation and archived ...
(Date:9/2/2015)... ... 02, 2015 , ... Whitehouse Laboratories is excited to announce ... Resources upcoming educational seminar and training session on Extractable & Leachable testing. Featuring ... provide Updates & Case Studies on the Latest Compliance Implications of USP and ...
Breaking Biology Technology:Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3
... DATATRAK International, Inc. (OTCQX: DATA), a technology and ... the clinical trials industry, today announced the addition ... Connect Partner Program.  The DATATRAK software suite complements ... processes using state-of-the-art clinical trial technology. ...
... TAIPEI, Taiwan, June 14, 2011 /PRNewswire-Asia/ -- TWi ... enrolled over 50% of the total 240 patients ... for the treatment of Type II Diabetes. The ... designed to evaluate the glycated hemoglglobin A1c (HbA1c) ...
... Twenty-two of America,s most promising scientists have been ... by The Pew Charitable Trusts.  The 2011 Pew Scholars ... recipients of the Albert Lasker Medical Research Award and ... of Scholars is related to many human diseases ranging ...
Cached Biology Technology:Research Dynamics Becomes DATATRAK Connect Partner 2Research Dynamics Becomes DATATRAK Connect Partner 3Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes 222 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences 222 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences 322 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences 4
(Date:9/2/2015)... Security of data and assets has ... organizations, telecommunications, hospitals, as well as individuals. Keys, ... used to prevent unauthorised access. Technological advancements resulted ... could gain access to secure premises after being ... devices and numeric codes. However, hackers also could ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015  Automation ... travelers during airport passenger screening. This is the ... passenger screening process will become unintrusive. An assortment ... based on voluntary background investigations will transform the ... Frost & Sullivan, Global Airport Passenger Screening ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Saudi Arabia Biomedical Sensors Market - Growth, Trends & ... The Saudi Arabia Biomedical Sensors market is estimated ... 3.64% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2
... in medicine. In the future, new tissue grown in a ... the place of damaged cells in the brain. Rather than ... and complicated scientific issues, scientists have been looking to adult ... stem cells are now being cultivated from various tissues in ...
... many serious diseases remain a mystery? In considering that ... School of Medicine has come up with a unified molecular ... may provide an answer. Reviewing findings from multiple ... and Molecular Medicine and Investigator with the Howard Hughes Medical ...
... Texas University of Texas Medical Branch at Galveston researchers ... which the Ebola Zaire virus infects cells a critical ... produced by the virus. Ebola produces severe and often ... close to 90 percent in some outbreaks. No vaccine or ...
Cached Biology News:Tel Aviv University researchers create new stem cell screening tool 2Do 68 molecules hold the key to understanding disease? 2Scientists uncover Ebola cell-invasion strategy 2
... use of small interfering RNA (siRNA) molecules ... interference (RNAi) pathway have generated tremendous interest ... siRNA for experimental use can be synthesized ... then transfected into the target cells in ...
... 12™ is an automated hybridization system for ... automates both the hybridization and post hybridization ... A single instrument can process up to ... and has multi-protocol software, enabling the user ...
... Uncover the biological data hidden in your samples ... manufacturing allows you to create your own microarray ... at your own pace and receive delivery of ... eArray is a secure, online array creation application ...
... the demands of the routine trace metal ... reliable, robust and simple to use instrumentation. ... the most challenging sample matrices found in ... to the toughest analytical challenges found in ...
Biology Products: